US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 253.740
- +0.390+0.15%
Close Nov 27 16:00 ET
- 253.740
- 0.0000.00%
Post 20:02 ET
32.73BMarket Cap-96847P/E (TTM)
256.020High250.270Low718.10KVolume253.980Open253.350Pre Close181.50MTurnover0.56%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High1010.92P/B32.59BFloat Cap141.97552wk Low--Dividend TTM128.44MShs Float304.390Historical High--Div YieldTTM2.27%Amplitude3.650Historical Low252.742Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet